AdaptHealth Corp. (NASDAQ:AHCO) Receives $14.00 Consensus PT from Brokerages

AdaptHealth Corp. (NASDAQ:AHCO) has received a consensus recommendation of “Moderate Buy” from the eight analysts that are presently covering the firm, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, two have given a hold rating and five have given a buy rating to the company. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $14.2857.

A number of analysts have recently commented on AHCO shares. Jefferies Financial Group restated a “hold” rating and set a $11.00 target price on shares of AdaptHealth in a report on Monday, April 20th. Robert W. Baird set a $18.00 target price on shares of AdaptHealth in a report on Wednesday, May 6th. Truist Financial lifted their price target on AdaptHealth from $13.00 to $14.00 and gave the stock a “buy” rating in a research report on Monday, April 13th. Leerink Partners lowered their price target on AdaptHealth from $13.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, February 26th. Finally, Wall Street Zen raised AdaptHealth from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th.

Insider Activity

In related news, major shareholder Richard M. Cashin, Jr. purchased 820,528 shares of the stock in a transaction dated Tuesday, March 10th. The stock was purchased at an average price of $9.73 per share, with a total value of $7,983,737.44. Following the transaction, the insider directly owned 14,638,708 shares in the company, valued at $142,434,628.84. This trade represents a 5.94% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Over the last ninety days, insiders bought 2,494,518 shares of company stock valued at $24,352,291. 1.95% of the stock is owned by insiders.

Hedge Funds Weigh In On AdaptHealth

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Rockefeller Capital Management L.P. raised its stake in shares of AdaptHealth by 433.0% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after purchasing an additional 2,100 shares during the last quarter. FNY Investment Advisers LLC purchased a new position in AdaptHealth in the 3rd quarter worth about $35,000. PNC Financial Services Group Inc. raised its position in AdaptHealth by 22.3% in the 4th quarter. PNC Financial Services Group Inc. now owns 7,003 shares of the company’s stock worth $70,000 after buying an additional 1,279 shares during the last quarter. Assetmark Inc. raised its position in AdaptHealth by 54.8% in the 1st quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after buying an additional 2,460 shares during the last quarter. Finally, Tower Research Capital LLC TRC raised its position in AdaptHealth by 318.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 9,592 shares of the company’s stock worth $90,000 after buying an additional 7,297 shares during the last quarter. 82.67% of the stock is owned by institutional investors.

AdaptHealth Stock Performance

Shares of AHCO stock opened at $10.66 on Monday. AdaptHealth has a 12 month low of $8.06 and a 12 month high of $13.43. The stock has a market cap of $1.45 billion, a PE ratio of -17.19, a price-to-earnings-growth ratio of 0.61 and a beta of 1.57. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 1.21. The company’s fifty day moving average price is $11.50 and its 200-day moving average price is $10.47.

AdaptHealth (NASDAQ:AHCO) last announced its earnings results on Tuesday, May 5th. The company reported ($0.12) EPS for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.13). AdaptHealth had a negative net margin of 2.42% and a positive return on equity of 2.76%. The business had revenue of $819.80 million for the quarter, compared to the consensus estimate of $796.63 million. During the same quarter last year, the firm posted ($0.05) EPS. The business’s quarterly revenue was up 5.4% on a year-over-year basis. On average, equities analysts expect that AdaptHealth will post 0.63 EPS for the current fiscal year.

AdaptHealth Company Profile

AdaptHealth, Inc operates as a leading provider of home medical equipment (HME) and related services in the United States. The company focuses on delivering respiratory care, mobility solutions and bathroom safety products to patients with chronic and acute medical needs. Through its comprehensive service offerings, AdaptHealth aims to enhance quality of life and clinical outcomes for patients who require long-term support outside of a hospital setting.

The company’s respiratory portfolio includes products such as continuous positive airway pressure (CPAP) devices, oxygen concentrators, ventilators, and associated supplies for patients with sleep apnea, COPD and other pulmonary conditions.